TRCT
SBBP

Tower Research Capital (TRC)’s Strongbridge Biopharma plc. SBBP Stock Holding History

Tower Research Capital (TRC)’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,657
Closed -$11K – 6551
2021
Q2 		$11K Sell
3,657
-2,825
-44% -$7.46K ﹤0.01% 4360
2021
Q1 		$18K Sell
6,482
-6,542
-50% -$19.7K ﹤0.01% 3984
2020
Q4 		$31K Sell
13,024
-40,439
-76% -$97.4K ﹤0.01% 3552
2020
Q3 		$112K Buy
53,463
+44,902
+524% +$151K ﹤0.01% 3070
2020
Q2 		$32K Buy
+8,561
New +$25.7K ﹤0.01% 3410
2019
Q4 		– Sell
-9,236
Closed -$23K – 4728
2019
Q3 		$23K Buy
9,236
+4,113
+80% +$11K ﹤0.01% 2390
2019
Q2 		$16K Buy
5,123
+848
+20% +$3.11K ﹤0.01% 2316
2019
Q1 		$21K Sell
4,275
-1,354
-24% -$6.67K ﹤0.01% 2254
2018
Q4 		$25K Buy
+5,629
New +$27.5K ﹤0.01% 1776
2018
Q3 		– Sell
-15,996
Closed -$96K – 4445
2018
Q2 		$96K Buy
+15,996
New +$117K 0.01% 1471
2016
Q4 		– Sell
-749
Closed -$4K – 4626
2016
Q3 		$4K Buy
+749
New +$3.38K ﹤0.01% 2751
2016
Q1 		– Sell
-1,094
Closed -$8K – 5237
2015
Q4 		$8K Buy
+1,094
New +$7.86K ﹤0.01% 2481

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Tower Research Capital (TRC)'s SBBP Position: Q3 2021 in Review

Tower Research Capital (TRC) sold out of Strongbridge Biopharma plc. (SBBP) in Q3 2021, closing a stake of 3,657 shares — an estimated $11K sold.

Tower Research Capital (TRC) first reported a position in SBBP in Q4 2015 and held it in 12 quarters. The position peaked at $112K in Q3 2020. 49 funds tracked by Wall St. Rank hold SBBP as of Q3 2021.

  • Tower Research Capital (TRC) reported no remaining Strongbridge Biopharma plc. position as of Q3 2021 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 3,657 Strongbridge Biopharma plc. shares in Q3 2021, an estimated $11K.
  • Tower Research Capital (TRC) first reported a position in Strongbridge Biopharma plc. in Q4 2015 and held it in 12 quarters.
  • Tower Research Capital (TRC)'s Strongbridge Biopharma plc. position peaked at $112K in Q3 2020.
  • 49 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q3 2021.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2021, filed 15 Nov 2021.